Phenotypes and genotypes of high density lipoprotein cholesterol in exceptional longevity

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

A change in the lipoprotein profile is a metabolic hallmark of aging and has been the target for modern medical developments. Although pharmaceutical interventions aimed at lipid lowering substantially decrease the risk of cardiovascular disease, they have much less impact on mortality and longevity. Moreover, they have not affected death from other age-related diseases. In this review we focus on high density lipoprotein (HDL) cholesterol, the levels of which are either elevated or do not decrease as would be expected with aging in centenarians, and which are associated with lower prevalence of numerous age-related diseases; thereby, suggesting a potential HDL-mediated mechanism for extended survival. We also provide an update on the progress of identifying longevity-mediating lipid genes, describe approaches to discover longevity genes, and discuss possible limitations. Implicating lipid genes in exceptional longevity may lead to drug therapies that prevent several age-related diseases, with such efforts already on the way.

Original languageEnglish (US)
Pages (from-to)690-697
Number of pages8
JournalCurrent Vascular Pharmacology
Volume12
Issue number5
StatePublished - 2014

Fingerprint

HDL Cholesterol
Genotype
Phenotype
Lipids
Genes
HDL Lipoproteins
Lipoproteins
Cardiovascular Diseases
Drug Therapy
Mortality
Pharmaceutical Preparations

Keywords

  • Aging
  • APOC3
  • CETP
  • Genetics
  • HDL
  • Longevity

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology

Cite this

@article{170820cdbea4487c869e60dc13da50cf,
title = "Phenotypes and genotypes of high density lipoprotein cholesterol in exceptional longevity",
abstract = "A change in the lipoprotein profile is a metabolic hallmark of aging and has been the target for modern medical developments. Although pharmaceutical interventions aimed at lipid lowering substantially decrease the risk of cardiovascular disease, they have much less impact on mortality and longevity. Moreover, they have not affected death from other age-related diseases. In this review we focus on high density lipoprotein (HDL) cholesterol, the levels of which are either elevated or do not decrease as would be expected with aging in centenarians, and which are associated with lower prevalence of numerous age-related diseases; thereby, suggesting a potential HDL-mediated mechanism for extended survival. We also provide an update on the progress of identifying longevity-mediating lipid genes, describe approaches to discover longevity genes, and discuss possible limitations. Implicating lipid genes in exceptional longevity may lead to drug therapies that prevent several age-related diseases, with such efforts already on the way.",
keywords = "Aging, APOC3, CETP, Genetics, HDL, Longevity",
author = "Sofiya Milman and Gil Atzmon and Crandall, {Jill P.} and Nir Barzilai",
year = "2014",
language = "English (US)",
volume = "12",
pages = "690--697",
journal = "Current Vascular Pharmacology",
issn = "1570-1611",
publisher = "Bentham Science Publishers B.V.",
number = "5",

}

TY - JOUR

T1 - Phenotypes and genotypes of high density lipoprotein cholesterol in exceptional longevity

AU - Milman, Sofiya

AU - Atzmon, Gil

AU - Crandall, Jill P.

AU - Barzilai, Nir

PY - 2014

Y1 - 2014

N2 - A change in the lipoprotein profile is a metabolic hallmark of aging and has been the target for modern medical developments. Although pharmaceutical interventions aimed at lipid lowering substantially decrease the risk of cardiovascular disease, they have much less impact on mortality and longevity. Moreover, they have not affected death from other age-related diseases. In this review we focus on high density lipoprotein (HDL) cholesterol, the levels of which are either elevated or do not decrease as would be expected with aging in centenarians, and which are associated with lower prevalence of numerous age-related diseases; thereby, suggesting a potential HDL-mediated mechanism for extended survival. We also provide an update on the progress of identifying longevity-mediating lipid genes, describe approaches to discover longevity genes, and discuss possible limitations. Implicating lipid genes in exceptional longevity may lead to drug therapies that prevent several age-related diseases, with such efforts already on the way.

AB - A change in the lipoprotein profile is a metabolic hallmark of aging and has been the target for modern medical developments. Although pharmaceutical interventions aimed at lipid lowering substantially decrease the risk of cardiovascular disease, they have much less impact on mortality and longevity. Moreover, they have not affected death from other age-related diseases. In this review we focus on high density lipoprotein (HDL) cholesterol, the levels of which are either elevated or do not decrease as would be expected with aging in centenarians, and which are associated with lower prevalence of numerous age-related diseases; thereby, suggesting a potential HDL-mediated mechanism for extended survival. We also provide an update on the progress of identifying longevity-mediating lipid genes, describe approaches to discover longevity genes, and discuss possible limitations. Implicating lipid genes in exceptional longevity may lead to drug therapies that prevent several age-related diseases, with such efforts already on the way.

KW - Aging

KW - APOC3

KW - CETP

KW - Genetics

KW - HDL

KW - Longevity

UR - http://www.scopus.com/inward/record.url?scp=84924137819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924137819&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 690

EP - 697

JO - Current Vascular Pharmacology

JF - Current Vascular Pharmacology

SN - 1570-1611

IS - 5

ER -